Fixed CPAP at 10 cmH 2 O May Replace Manual Titration in Moderate to Severe OSA Patients: A Preliminary Randomised Controlled Trial
Respirology · 2025
DOI: 10.1111/resp.70037 ↗At a glance
Randomisierte kontrollierte Studie in Respirology, 2025. Written by Lu Wang and 10 co-authors. Institution: State Key Laboratory of Respiratory Disease, Guangzhou Medical University, Guangzhou, China. Major MEDLINE topics: Continuous Positive Airway Pressure, Sleep Apnea, Obstructive. Cited 3 times so far (Crossref); 28 references. The full text is freely available (open access, CC BY-NC-ND 4.0). Funded by: Guangzhou Municipal Health Commission Major Technical Project Grant, National Natural Science Foundation of China, China Postdoctoral Science Foundation.
Abstract (original language)
Background and Objectives Patient compliance with continuous positive airway pressure (CPAP) is similar using manual‐titrated pressure compared to auto‐titration, although auto‐titration pressures are usually 2–5 cmH 2 O higher than manual pressure, indicating that CPAP moderately higher than the optimal pressure will not necessarily impair compliance. We try to find the tolerable highest CPAP which does not increase respiratory effort based on changes in lung volume, diaphragm electromyography (EMG) and breathing sensations in healthy volunteers and OSA patients to simplify pressure titration.
Methods
Part 1, 12 healthy subjects and 16 OSA patients were enrolled in the measurement of expiratory reserve volume, diaphragm EMG, and expiratory muscle EMG at different CPAP levels. Breathing difficulty during different CPAP levels was assessed using a customised questionnaire in 35 healthy subjects and 33 OSA patients. Part 2, a two‐night randomised crossover double‐blind trial using the tolerable highest CPAP (10 cmH 2 O) based on the results derived from Part 1 and the manually titrated pressure was performed in 25 OSA patients.
Results
End expiratory lung volume increased significantly with increasing CPAP. In general, diaphragm EMG changed little when CPAP ≤ 10 cmH 2 O. Expiratory muscle activity appeared when CPAP > 12 cmH 2 O. There was no significant difference in subjective sensation of breathing difficulty with CPAP ≤ 10 cmH 2 O. Sleep structure, AHI, and patient preference with 10 cmH 2 O CPAP were not different from those under titrated pressure.
Conclusions
This study suggests that most patients with moderate to severe OSA can be effectively treated with CPAP at an initial pressure of 10 cmH 2 O without pressure titration. Trial Registration: ClinicalTrials.gov identifier: NCT04925466
Subjects
MeSH terms (MEDLINE)
Author keywords
Authors and institutions
- State Key Laboratory of Respiratory Disease, Guangzhou Medical University, Guangzhou, China.
- Guy's & St Thomas' NHS Foundation Trust and King's College London, London, UK.
- AISH, Flinders University, Adelaide, Australia.
- Division of Sleep and Circadian Disorders, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts, USA.
ORCID profiles: Lu Wang
Funding
- Guangzhou Municipal Health Commission Major Technical Project Grant
- National Natural Science Foundation of China
- China Postdoctoral Science Foundation
Cite
APA
Wang, L., Chen, Y., Wei, Q., Wu, Y., Huang, C., Liang, S., Steier, J., Catcheside, P., Eckert, D., Wellman, A., & Luo, Y. (2025). Fixed CPAP at 10 cmH 2 O May Replace Manual Titration in Moderate to Severe OSA Patients: A Preliminary Randomised Controlled Trial. Respirology. https://doi.org/10.1111/resp.70037
Vancouver
Wang L, Chen Y, Wei Q, Wu Y, Huang C, Liang S, et al. Fixed CPAP at 10 cmH 2 O May Replace Manual Titration in Moderate to Severe OSA Patients: A Preliminary Randomised Controlled Trial. Respirology. 2025. doi:10.1111/resp.70037
BibTeX
@article{Wang2025,
author = {Wang, Lu and Chen, Yan and Wei, Qishan and Wu, Yingxin and Huang, Cuizhen and Liang, Shanfeng and Steier, Joerg and Catcheside, Peter and Eckert, Danny and Wellman, Andrew and Luo, Yuanming},
title = {Fixed CPAP at 10 cmH 2 O May Replace Manual Titration in Moderate to Severe OSA Patients: A Preliminary Randomised Controlled Trial},
journal = {Respirology},
year = {2025},
doi = {10.1111/resp.70037}
}
EUVIMED